Lyell Immunopharma, Inc. (LYEL)

SEC filing

Lyell Immunopharma, Inc.

LYEL · CIK 1806952

4 · Oct 13, 2026 · Chief Medical Officer Aguirre Jarrad Mattieu sold 422 shares at $8.63/share ($3,642)

Chief Medical Officer Aguirre Jarrad Mattieu sold 422 shares at $8.63/share ($3,642)

xslF345X06/form4-10132026_091052.xml

xslF345X06/form4-10132026_091052.xmlSEC.gov

Graphics and non-inline formats (not embedded below).